← Leaderboards
Ralph Baric
Univ Of North Carolina Chapel Hill
$4,822,361
Attributed
$4,822,361
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2019–24$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,822,361 · 1
By mechanism
N01$4,822,361 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Brian Patrick Conlon$5,321,207
- Martina Gentzsch$4,061,372
- Vineet D Menachery$15,198,106
- Lance R. Thurlow$1,700,975
- Edward J Beecham$788,809
Others in their field
Other Emerging Leaders on “Infectious Disease Model”
- Ted Ross · University Of Georgia$71,962,304
- Prasant Mohapatra · University Of California At Davis$54,605,575
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr$18,698,011
- David Beasley · University Of Texas Med Br Galveston$16,507,955
- Greg Westergaard · Alpha Genesis Inc$15,750,123
Research focus
Infectious Disease ModelContractsStandardizationLicensureAnimal ModelEfficacy TestingAnimal Model Development2019-NcovAntimicrobial ResistanceChronicCoronavirusCovid-19Cystic Fibrosis MouseEvaluationMedical CountermeasurePseudomonas AeruginosaScreeningStaphylococcus AureusImmunogenicityStaphylococcus Aureus InfectionCovid-19 TherapeuticsBiological ProductsVaccine EvaluationBiological Models
Grant awards (9)
Task A92: Efficacy of Antiviral Therapeutics Against MERS-CoV in a Mouse-Adapted Virus Model$637,479
N01 · FY2024 · AI · contact PI
Task A68: Screening Vaccine (and Other Biologics) Platform Technologies using Coronavirus Mouse Immunogenicity as a Model System$563,541
N01 · FY2024 · AI · contact PI
Task A68: Screening Vaccine (and Other Biologics) Platform Technologies using Coronavirus Mouse Immunogenicity as a Model System$563,541
N01 · FY2022 · AI · contact PI
Task A38: Establishment of Small Animal Models for Screening Medical Countermeasures for the 2019 Novel Coronavirus (2019-nCoV)$390,168
N01 · FY2022 · AI · contact PI
Task A24: Establishment of Chronic Pseudomonas aeruginosa and Staphylococcus aureus Infection in Mouse Models of Cystic Fibrosis$492,456
N01 · FY2021 · AI · contact PI
Task A38: Establishment of Small Animal Models for Screening Medical Countermeasures for the 2019 Novel Coronavirus (2019-nCoV)$223,203
N01 · FY2021 · AI · contact PI
Task A38: Establishment of Small Animal Models for Screening Medical Countermeasures for the 2019 Novel Coronavirus (2019-nCoV)$857,754
N01 · FY2020 · AI · contact PI
Task A24: Establishment of Chronic Pseudomonas aeruginosa and Staphylococcus aureus Infection in Mouse Models of Cystic Fibrosis$652,090
N01 · FY2020 · AI · contact PI
ESTABLISHMENT OF CHRONIC BACTERIAL INFECTION MODELS IN MOUSE MODELS OF CYSTIC FIBROSIS WITH PSEUDOMONAS AERUGINOSA AND STAPHYLOCOCCUS AUREUS$442,129
N01 · FY2019 · AI · contact PI